Health Care

Cozen O’Connor provides sophisticated counsel to a wide variety of investors and operators within the health care industry.  Our market advantage is our deep understanding of the legal regulatory framework and reimbursement in the space.  We provide practical and cost-effective solutions. We help them manage risk and seize opportunities in this era of regulatory uncertainty, government scrutiny, innovation, challenging economics, and shifting demographics.

The firm focuses on transactional health care, reimbursements, regulatory matters, and health care litigation. We represent private equity and venture capital investors, health systems, hospitals, physician groups, long-term care and nursing home providers, life sciences and health technology companies, suppliers, drug and device companies, and health care entrepreneurs.

Our multi-disciplinary health care team includes attorneys with decades of relevant health care regulatory, litigation, and transactional experience.

Cozen O’Connor stands out from other large law firms for being able to provide comprehensive health law services nationwide, while maintaining an entrepreneurial business model that can accommodate businesses at different stages of their life-cycle and provide optimal value to our clients.

Our Health Law Group represents clients in the areas of:

 

Health Care Transactions

Cozen O’Connor’s full-service corporate practice handles complex business transactions for health clients, including mergers and acquisitions, divestitures, joint ventures and co-management agreements, venture capital and private equity investments, public offerings, and recapitalizations. We also assist with antitrust due diligence and reporting, as well as tax analysis and structuring.

Modern health care institutions require legal counsel who are well-versed in both corporate law and health law in order to complete major transactions. Whether arranging venture capital funding for a health technology startup or executing a hospital merger, Cozen O’Connor brings sophisticated understanding of business, finance, health industry operations, and health regulations to every deal.

We serve as transactional counsel for hospitals, health systems, physician groups, ACOs, clinically integrated networks, medical device manufacturers, private equity sponsors and portfolio companies, academic medical centers, and research organizations.

Our health care team provides counsel on transactions unique to the health care industry. We form ACOs, clinically integrated networks and physician practice groups, and negotiate contracts between providers and a multitude of different vendors. Cozen O’Connor represents management service organizations (MSOs), contract research organizations (CROs), tissue banks, and other nonprofit data centers. Clients rely on Cozen O’Connor’s detailed understanding of the health care business, health IP, payor policies, and federal research guidelines. 

 

Payer Contracts & Value-Based Programs

Given the current regulatory climate, the need for clear and enforceable payer contracts has never been greater. The Health Law Practice at Cozen O’Connor counsels major health care clients in the areas of payer contracts, clinical integration, and value-based payment programs.

Cozen O’Connor represents health systems, hospitals, and large physician groups. Our attorneys are well versed in the intricacies of payer contracts and their practical implications.

Our Health Law Practice offers start-to-finish contract counsel. We negotiate payer contracts of all types and provide advice on cutting-edge contracting issues, such as utilization management, “tiering and steering,” and the impact of corporate structure on government payment eligibility. We provide sophisticated front-end payer contract counsel, and defend and enforce payer contracts in high-stakes payment disputes.

Cozen O’Connor is a recognized leader in value-based contracting and related risk-based payment programs. We also structure accountable care organizations and clinically integrated networks.

 

Payment Disputes

Cozen O’Connor is nationally known as a “go-to firm” for reimbursement disputes. Clients draw on our deep knowledge of laws governing the Medicare and Medicaid programs, as well as the financial and operational considerations specific to public and private-payor disputes.

The firm represents health systems, hospitals, and drug and device companies in litigation against private insurers, the federal government and state programs. The scope of our experience is vast and includes work on some of the most technically and legally complex disputes of the last decade.

We advise on issues involving: Medicare certification, premium subsidies, diagnosis-related groups (DRGs), site-of-service, out-of-network reimbursement, network termination, suspension of payments, continuity-of-care, recoupments, coding downgrades, coverage, ERISA, sequestration, and intergovernmental transfers. We have had cases before the Provider Reimbursement Review Board (PRRB) and the Departmental Appeals Board (DAB) of the Department of Health and Human Services and regularly appear in state and federal courts on behalf of our clients.

Cozen O’Connor’s practice is unusual in that we are capable of managing large multi-state or multi-plaintiff reimbursement litigation, but are also flexible enough to adjust our service model to meet specific client needs, including through use of alternative or contingency fee agreements.

 

Health Care Government Investigations

Cozen O’Connor defends health care clients in high-stakes federal and state agency investigations and litigation, including actions involving False Claims Act, qui tam, Anti-Kickback, Stark Law, and Sunshine Act claims. We are known for our ability to achieve early and decisive resolutions.

 

HIPAA & Health Data

No entity can operate in the health care field without paying constant and careful attention to health data privacy and security. Cozen O’Connor’s Health Law Practice helps major corporate clients meet the challenges of achieving regulatory compliance and keeping health data secure.

Cozen O’Connor represents HIPAA-defined “covered entities” (health systems, hospitals, physician groups, and other providers) and “business associates.” Cozen O’Connor also advises clients handling health care data outside the HIPAA regulatory structure, such as wellness programs, wearable devices, and websites. Our attorneys closely track health privacy and security laws, including HIPAA and HITECH, FTC, FDA, Gramm-Leach-Bliley, the GDPR, U.S. Privacy Shield, alcohol and drug abuse records, federal communications and trade statutes, and myriad state-based privacy and data breach laws.

Among the most important services Cozen O’Connor provides is comprehensive loss prevention. Our attorneys conduct deep-dive audits under the umbrella of attorney-client privilege; develop policies and procedures that integrate sophisticated physical, technical, and administrative safeguards; conduct client training on data privacy and security compliance; and draft and review contracts with business associates, subcontractors, and institutional partners.

In response to an alleged privacy violation or data breach, the Health Law team can perform immediate forensic and recovery operations, satisfy notification obligations, liaison with government officials, and design public messages to protect clients from liability. We lead complex internal investigations for high-profile health clients and represent them in federal and state government regulatory investigations, enforcement actions, state attorneys general litigation, class actions, and individual plaintiff lawsuits.

The firm’s work in health data privacy and security is significantly bolstered by our strong Washington, D.C.,-based government affairs and state attorneys general groups. Cozen O’Connor Public Strategies is at the forefront of tracking legislative developments on health data, and the firm’s 50-state AGs practice is well positioned to assist as regulatory responsibility devolves to the state level.

 

Digital Health

New technologies are transforming health care in America. From the growth in telehealth and telemedicine to the revolution in electronic data collection and analysis, digital health is affecting nearly every aspect of health care delivery.

Cozen O’Connor is a leader in digital health law. We represent innovative telehealth and telemedicine companies, technology companies, health care analytics firms, provider groups, and medical device manufacturers. Our attorneys bring decades of diverse experience in health care, technology, and emerging business development and provide comprehensive regulatory and corporate counsel.

We advise innovative digital health clients on compliance with analogue-era regulatory requirements, including all state and federal privacy and security rules; health fraud and abuse laws; and FCC, FDA, FTC, and state consumer protection requirements.

Our attorneys also provide integrated corporate counsel, assisting technology firms and health care companies on corporate structure, private equity, IP, commercialization, licensing, marketing, and contracts. We partner with emerging companies through every stage of their business life cycle. Our attorneys advise digital and tech-focused companies on medical liability risk management and coverage and reimbursement strategies with both government and private payors.

Cozen O’Connor not only advocates for individual clients, but also for the digital health industry. Through our Washington, D.C.,-based Public Strategies firm and State Attorneys General practice, we provide top-ranked government relations support. We track relevant legislative activity, advocate before state and federal governments, and build effective trade associations and policy-based coalitions.

 

Government Affairs

Cozen O’Connor Public Strategies, the firm’s bipartisan Washington, D.C.,-based government relations firm, provides outreach to public officials on matters of health law and policy. We advocate for clients before the Centers for Medicaid & Medicare Services, Department of Justice, Food & Drug Administration, state departments of health & welfare, and state and federal legislatures.

 

Medical Marijuana

The increased use of cannabis for medical purposes presents health care institutions, providers, and suppliers with a complex set of legal considerations. Cozen O’Connor has an interdisciplinary team of attorneys ready to advise on all applicable state and federal laws.

 

State Attorneys General

With one of the largest state attorneys general practices in the country, Cozen O’Connor represents clients in state AG investigations and litigation (including multi-state and federal co-enforcement actions). The State AG team has experience counselling health care clients faced with state-based consumer protection, antitrust, false claims, drug pricing, and data privacy claims.

 

Experience

Publications

Will The Standard of Liability Under The 60-Day Repayment Rule Change? [Health Law Informer Blog]

February 21, 2023

At the end of last year, the Centers for Medicare & Medicaid Services (CMS) proposed changes to the so-called 60-day repayment rule. The proposed changes include eliminating the current “reasonable diligence” standard that applies to providers in connection with potential liability for...

New Jersey Health Care Entities Should Add New Employee Protections to Their Due Diligence Checklists [Alert]

October 28, 2022

New Jersey Senate Bill No. 315 creates broad protections for many employees in the health care sector in the event of a change in control.

New Protections for Employees of Certain New Jersey Health Care Entities [Health Law Informer Blog]

October 27, 2022

Health care entities, home health care agencies, and staffing registries considering a transaction in New Jersey will need to keep in mind new obligations to certain employees. On August 18, 2022, Governor Murphy signed into law New Jersey Senate Bill No. 315 (the “Act”), which created broad...

En Banc Fourth Circuit Affirms Dismissal of False Claims Act Lawsuit and Vacates Panel Opinion [Health Law Informer Blog]

October 14, 2022

We previously reported that the Fourth Circuit, via a 2-1 decision in United States ex rel. Sheldon v. Allergan Sales, LLC, 24 F.4th 340 (4th Cir. 2022), affirmed the dismissal of a False Claims Act (“FCA”) qui tam lawsuit against Forest Laboratories, LLC (“Forest”). The plaintiff alleged that...

Industry Interactions with Physicians Continue to be a Hot Topic for Civil False Claims Act Enforcement Actions under Private Qui Tam Litigation [Health Law Informer Blog]

October 06, 2022

In a continuing wave of fraud and abuse civil enforcement actions brought by qui tam relators, big pharma giant, Biogen, is the latest corporate actor to reach a mega settlement with the U.S. Department of Justice (DOJ) for allegations of False Claims Act liability for paying bribes to physicians...

HIPAA “Right of Access” Enforcement Trend Continues [Health Law Informer Blog]

September 27, 2022

The Office of Civil Rights of the Department of Health and Human Services (“OCR”) announced the resolution of three more right of access cases, bringing the total to a whopping 41 since the start of its drive to increase compliance with this Health Insurance Portability and Accountability Act...

Sham Transactions in Digital Health Industry [Health Law Informer Blog]

September 23, 2022

In its recently published Special Fraud Alert, the Office of Inspector General (“OIG”) presented a list of suspect characteristics related to arrangements with telehealth and telemedicine companies, which may help determine the potential for fraud. The OIG developed this list based on dozens of...

New Final Rules under the No Surprises Act: Four Takeaways [Health Law Informer Blog]

September 14, 2022

On August 19, 2022, the United States Departments of Health and Human Services, Labor and Treasury released final rules (“Final Rules”) revising certain provisions of their previously issued interim final rules regarding the No Surprises Act (“NSA”). The revisions reflect some comments received...

Office of Civil Rights Releases Patient Privacy Guidance in the Wake of Dobbs Decision [Health Law Informer Blog]

July 01, 2022

Patient privacy concerns are at an all-time high following the Supreme Court’s ruling in Dobbs v. Jackson Women’s Health Organization. Following their statements affirming that abortion constitutes basic and essential health to which every woman should be entitled issued by both Xavier Becerra,...

CMS Releases Second Set of FAQs Regarding Good Faith Estimates to Uninsured and Self-pay Patients Under “No Surprises Act” [Health Law Informer Blog]

April 06, 2022

CMS continued to roll out guidance regarding the No Surprises Act. The latest guidance is the second set of FAQs regarding the Good Faith Estimate Requirement for uninsured and self-pay patients was issued on April 5, 2022. The FAQs address six questions regarding the requirement and can be found...

Federal District Court Partially Guts Regulations Affecting the No Surprises Act Arbitration Process [Health Law Informer Blog]

March 30, 2022

On February 23, 2022, the U.S. District Court for the Eastern District of Texas gutted portions of the interim final rule affecting the independent dispute resolution (“IDR”) process of the No Surprises Act (the “Act”). Tex. Med. Ass’n v. U.S. Dep’t of Health & Human Servs., No....

Fourth Circuit Adopts Safeco Scienter Standard to Prove False Claims Act Violation in Legal Falsity Cases [Health Law Informer Blog]

March 09, 2022

A few weeks ago, the U.S. Court of Appeals for the Fourth Circuit answered a critical inquiry in the False Claims Act (“FCA”) context: does a defendant violate the FCA when its reading of the regulation is objectively reasonable and there is no government guidance discouraging or rejecting that...

Compliance with the hospital price transparency law almost a year in: Where are we now? [Cosmos]

December 01, 2021

Christopher Raphaely and Danielle Sapega co-authored an article about the Centers for Medicare & Medicaid Services (CMS) hospital price transparency rule, which has been in effect since January 1, 2021.

Five Things Providers Need To Know About The New Interim Final Rule Under The “No Surprises” Act [Health Law Informer Blog]

October 05, 2021

On Thursday, September 30, 2021, The United States departments of Health and Human Services (“HHS”), Labor and Treasury released an interim final rule (“Rule”) that completes most of the regulatory framework under the federal No Surprises Act (“Act”). The Act largely bars balance billing of...

US and Tyler Texas Chambers of Commerce Sue Feds to Block Portions of the Health Plan Transparency Rule [Health Law Informer Blog]

August 12, 2021

Two chambers of commerce, the Chamber of Commerce the United States of America and the Tyler (TX) Area Chamber of Commerce, filed a lawsuit on August 10, 2021, in the US District Court for the Eastern District of Texas against the United States departments of Health and Human Services, Labor and...

Prescription Privileges for Psychologists: The State of Play [American Bar Association]

July 28, 2021

Gregory Fliszar and Ryan Portugal co-authored an article examining the arguments for and against psychologists obtaining prescription privileges for psychotropic drugs and a look at the five states that have granted such privileges to psychologists.

HHS, Treasury and Labor Release First Set of Surprise Billing Rules [Health Law Informer Blog]

July 02, 2021

The United States Departments of Health and Human Services, Treasury and Labor released interim final rules (“Rules”) regarding the “No Surprises Act” (“Act”) yesterday. The Rules are effective beginning on January 1, 2022. They cover the requirements for the billing and payment of emergency and...

AstraZeneca Sues HHS over Drug Pricing Program Advisory Opinion Regarding Contract Pharmacies

February 01, 2021

Corrine Zucker discusses AstraZeneca's complaint filed in Delaware federal court against HHS for issuing an invalid Advisory Opinion

Repeal of McCarran-Ferguson Act — Ramifications for Insurance Clients

January 25, 2021

Jonathan Grossman discusses how the Competitive Health Insurance Reform Act will impact health insurance companies, as they are now no longer immune from antitrust scrutiny for activities previously found to be “the business of insurance.”

Northern District of California Grants Preliminary Injunction Against Most Favored Nation Rule [Health Law Informer Blog]

December 29, 2020

On December 28, 2020, the District Court for the Northern District of California granted a motion for a preliminary injunction enjoining the Centers for Medicare and Medicaid Services from implementing the Most Favored Nation Rule (the “Rule”, summarized in our December 23 post) until the notice...

District Court grants TRO on Most Favored Nation Rule [Health Law Informer Blog]

December 23, 2020

On December 23, 2020, The District Court for the District of Maryland granted a temporary restraining order temporarily ceasing the implementation of the Centers for Medicare and Medicaid Services’ (“CMS”) Most Favored Nations Rule (the “Rule”) for fourteen (14) days. The Rule, published on...

CMS Releases Final Stark Rules To Promote Value-Based Care [Health Law Informer Blog]

November 23, 2020

On Friday, November 20, 2020, the Centers for Medicare and Medicaid Services (“CMS”) released final regulations to remove certain barriers to the implementation of physician compensation arrangements under value-based payment arrangements posed by the “Stark” Physician Self-Referral law. The...

Trump vs. Biden: HEALTH CARE POLICY

October 28, 2020

Alex Campau, Mark Alderman, and Brett Banker discuss the similarities and differences between Trump and Biden's health care policies.

Pennsylvania Attorney General Announces Nursing Home Criminal Investigations [Alert]

May 15, 2020

Danielle Sapega discusses the Pennsylvania attorney general's investigation into nursing homes, the Department of Health's guidance for nursing homes, and the governor's executive order granting immunity to health care workers.

Pennsylvania Hospitals Can Now Resume Elective Surgeries and Procedures [Alert]

April 29, 2020

Gregory M. Fliszar discusses what measures Pennsylvania hospitals must take before resuming elective surgeries and procedures.

CMS Issues Blanket Waivers for Long-Term Care Facilities, SNFs and NFs

April 29, 2020

J. Nicole Martin and Gregory M. Fliszar discuss CMS's blanket waivers for nursing facilities and skilled-nursing facilities effective through the end of the COVID-19-related emergency.

CMS Issues Recommendations to Reopen Health Care Systems in Areas with Low Incidence of COVID-19 [Alert]

April 20, 2020

J. Nicole Martin and Gregory M. Fliszar discuss CMS's guidance for health care systems in areas with low COVID-19 infections to reopen nonessential care.

CMS Announces Enhanced Nursing Home Reporting Requirements

April 20, 2020

Danielle E. Sapega and Gregory M. Fliszar discuss CMS's new guidance for nursing homes when it comes to reporting confirmed or suspected cases of COVID-19.

OCR Releases Notification of Enforcement Discretion at COVID-19 Community-Based Testing Sites [Alert]

April 14, 2020

Danielle Sapega and Gregory M. Fliszar discuss OCR's announcement relaxing HIPAA rules in connection with the good faith participation in the operation of a COVID-19 Community-Based Testing Site(s)

CMS Releases Details on $30 Billion Payment to Hospitals and other Health Care Providers [Alert]

April 14, 2020

Gregory M. Fliszar and Alexandra Campau explain the terms and conditions outlined by CMS for providers who wish to receive a payment from the Public Health and Social Services Emergency Fund.

First $30 Billion to be Immediately Distributed to Hospitals, Other Health Care Providers

April 09, 2020

Gregory M. Fliszar discusses CMS's announcement that $30 billion will be distributed from the health care provider relief fund in the CARES Act.

OCR Loosens Restrictions on Business Associates in Response to the COVID-19 Pandemic [Alert]

April 03, 2020

Gregory M. Fliszar explains HHS's announcement that it will exercise its enforcement discretion and will not impose penalties for violations of certain provisions of the HIPAA Privacy Rule against health care providers or their business associates for the good faith uses and disclosures of protected health information.

Summary and Analysis of Key Provisions of the CARES Act

March 28, 2020

Members of Cozen O'Connor's Coronavirus Task Force provide analysis of the CARES Act and how it will impact small businesses, distressed industries, employers and employees, taxes, and the health care, real estates, and energy industries.

OCR Releases Guidance on the Disclosure of PHI to First Responders and Public Health Authorities [Alert]

March 26, 2020

Danielle E. Sapega and Gregory M. Fliszar discuss the latest guidance from OCR on when it is permissible to disclose the minimum necessary information of individuals infected with COVID-19.

The Use of Telehealth During the COVID-19 Nationwide Public Health Emergency [Alert]

March 23, 2020

Greg Fliszar and Chris Raphaely explain the recent changes OCR and HHS made to make telehealth services more available.

HHS Issues EMTALA Waivers As a Result of the COVID-19 Pandemic [Alert]

March 18, 2020

Greg Fliszar discusses HHS's waiver of certain requirements of EMTALA in an effort to help hospitals being overrun and having capacity issues in their emergency rooms as a result of the COVID-19 pandemic.

HIPAA and COVID-19: Balancing Public Health Concerns and Patient Privacy in the Midst of a Pandemic [Alert]

March 13, 2020

Gregory M. Fliszar and Danielle Sapega discuss the HIPAA Privacy and Novel Coronavirus bulletin and what providers and covered entities need to know during a public health emergency.

Here is Your Opportunity to Tell HHS How to Improve HIPAA

December 12, 2018

Ryan P. Blaney and Alexandra Campau discuss the 32-page RFI released by the U.S. Department of Health and Human Services Office for Civil Rights.

Gaps in the Pennsylvania Medical Marijuana Law [The Journal of Lancaster General Hospital]

December 03, 2018

Danielle Sapega wrote about the rise of medical marijuana and the growing trends.

FDA Issues Final Guidance on “Labeling for Biosimilar Products” [Alert]

October 18, 2018

The guidance emphasizes biosimilarity while recognizing key differences between biosimilar and reference products.

The Medicare Shared Savings Program and the New Glide Path to Risk [Health Law Alert]

August 22, 2018

Chris Raphaely discusses CMS's proposed rule regarding ACOs in the Medicare Shared Savings Program.

Health Law Handbook 2018 Edition [Thomson Reuters]

June 22, 2018

Mark Gallant, Robert Chu, and Greg Fliszar all of Cozen O'Connor's Health Law group, co-authored the chapter titled, “Medicaid Managed Care” contained in Thomson Reuters’ newly released Health Law Handbook 2018 Edition.

Third Circuit Provides Guidance on Handling of EMTALA Whistleblower Claims [Labor & Employment Alert]

June 20, 2018

Bobbi Britton Tucker discusses the court's decision in Marie Gillispie v. Regionalcare Hospital Partners, Inc., and how the court rules that the EMTALA’s whistleblower provision protects employees who inform personnel in a covered facility of an alleged EMTALA violation, even though the employee does not also inform any governmental or regulatory agency.

Events & Seminars

Past Events

Spring Institute

March 18, 2022 - Philadelphia, PA

PBI Health Law Institute 2022

March 15, 2022 - Webinar

Health Law 2022

December 08, 2021 - Webinar

New Vaccine Mandates from Biden Administration

September 23, 2021 - Webinar

Telehealth in the New Administration

June 11, 2021 - Webinar

Price Transparency

March 16, 2021 - Webinar

Health Law 2021

December 07, 2020 - Webinar

PBI Health Law Institute 2020

March 11, 2020 - Philadelphia, PA

Health Law 2020

December 04, 2019 - Philadelphia, PA

Best Practices for Working with Your Outside Counsel

November 19, 2019 - Philadelphia, PA

PBI Health Law Institute 2019

March 12, 2019 - Philadelphia, PA

Health Law 2019

December 05, 2018 - Philadelphia, PA

CTeL Executive Telehealth Fall Summit 2018

December 04, 2018 - Washington, D.C.

PBI: A Day on Health Law

October 23, 2018 - Philadelphia, PA

Health, Biotech & Pharma Law CLE Institute

July 18, 2018 - King of Prussia, PA

In The News

Cozen O’Connor Recognized as a “Best Law Firm” in 30 Practice Areas Nationwide, 115 Practice Areas Regionally

November 30, 2022

U.S. News & World Report and Best Lawyers recognized Cozen O’Connor as a “Best Law Firm” in 30 practice areas nationwide and 115 practice areas regionally.

More Than 200 Cozen O’Connor Attorneys Named Best Lawyers and Ones to Watch

August 22, 2022

210 Cozen O’Connor lawyers from 24 of the firm’s nationwide offices for inclusion in the 2023 edition of The Best Lawyers in America.

13 Cozen O'Connor Attorneys Named 2022 D.C. Super Lawyers and Rising Stars

July 12, 2022

Super Lawyers has named 13 Cozen O’Connor attorneys to its 2022 Washington D.C. Super Lawyers and Rising Stars lists.

Cozen O'Connor Attorneys Appointed by the American Bar Association

July 01, 2022

The American Bar Association (ABA) has appointed Gregory Fliszar and Aselle Kurmanova to leadership positions in their Health Law and Business Law sections.

Chambers Ranks 86 Cozen O’Connor Lawyers, 22 Practice Areas in Chambers USA 2022 Guide

June 02, 2022

Chambers USA, the leading annual guide to the top lawyers and law firms in the United States, has ranked 86 Cozen O’Connor lawyers as leaders in their respective fields in the guide’s 2022 edition.

49 Cozen O'Connor Attorneys Named Pennsylvania Super Lawyers and Rising Stars

June 01, 2022

Super Lawyers has selected 49 Cozen O'Connor attorneys to the 2022 Pennsylvania Super Lawyers and Rising Stars lists.

Cozen O’Connor Continues Expansion of Health Care Practice Hiring Litigator James Billings-Kang

November 08, 2021

James will advise the firm’s health care clients in connection with litigation matters arising from provider-payor disputes, False Claims Act matters, private equity transactions, and merger activity, in addition to other complex commercial litigation issues.

Cozen O’Connor Recognized as a “Best Law Firm” in 29 Practice Areas Nationwide, 121 Practice Areas Regionally

November 04, 2021

U.S. News & World Report and Best Lawyers recognized Cozen O’Connor as a “Best Law Firm” in 29 practice areas nationwide and 121 practice areas regionally.

Cozen O’Connor Adds Distinguished Patent Counselor and Life Sciences Strategist Todd B. Buck, Ph.D. to the Washington, D.C. Intellectual Property and Business Law Practices

September 22, 2021

Buck brings an impressive resume with over two decades of experience in the life sciences intellectual property sector.

More Than 205 Cozen O’Connor Attorneys Named Best Lawyers and Ones to Watch By The Best Lawyers In America

August 19, 2021

Best Lawyers selected 210 Cozen O’Connor lawyers from 23 of the firm’s nationwide offices for inclusion in the 2022 edition of The Best Lawyers in America.

47 Cozen O'Connor Attorneys Named Pennsylvania Super Lawyers and Rising Stars

May 28, 2021

Super Lawyers has selected 47 Cozen O'Connor attorneys to the 2021 Pennsylvania Super Lawyers and Rising Stars lists.

82 Cozen O’Connor Lawyers, 19 Practices Earn Top Recognition in Chambers USA 2021 Guide

May 26, 2021

Chambers USA, the leading annual guide to the top lawyers and law firms in the United States, has ranked 82 Cozen O’Connor lawyers as leaders in their respective fields in the guide’s 2021 edition; of those, 15 lawyers have been recognized nationally.

Cozen O’Connor Continues Expansion of Health Care Practice with Aselle Kurmanova

May 18, 2021

Kurmanova joins the firm from Seyfarth Shaw LLP, reuniting with John Shire, who joined the firm in November 2020.

4 healthcare antitrust issues to watch

March 01, 2021

Jonathan Grossman was featured in an article published by Healthcare Dive discussing four health care antitrust issues to watch.

Cozen O’Connor Recognized as a “Best Law Firm” in 25 Practice Areas Nationwide, 115 Practice Areas Regionally

November 05, 2020

U.S. News & World Report and Best Lawyers recognized Cozen O’Connor as a “Best Law Firm” in 25 practice areas nationwide and 115 practice areas regionally.

Cozen O’Connor Makes Strategic Move Adding John D. Shire to Washington, D.C. Health Care Practice

November 02, 2020

Shire brings a deep understanding of federal and state health care regulations and has been instrumental in several of the most well-known transactions in the health care space.

More Than 200 Cozen O’Connor Attorneys Named Best Lawyers and Ones to Watch By The Best Lawyers In America

August 20, 2020

Best Lawyers selected 201 Cozen O’Connor lawyers from 23 of the firm’s nationwide offices for inclusion in the 2021 edition of The Best Lawyers in America© (Copyright 2020 by Woodward/White, Inc., of Aiken, SC).

63 Cozen O’Connor Lawyers, 16 Practices Earn Top Recognition in Chambers USA 2020 Guide

May 14, 2020

Chambers USA, the leading annual guide to the top lawyers and law firms in the United States, has ranked 63 Cozen O’Connor lawyers as leaders in their respective fields in the guide’s 2020 edition.

Psychiatrists start support line for doctors fighting coronavirus

May 07, 2020

Greg Fliszar and a group of psychiatrists launched the Physician Support Line to help doctors deal with the stress of combating the coronavirus crisis, with more than 600 people now volunteering in shifts to help.

Pro Bono Lawyers at Weber Gallagher, Cozen O'Connor and Other Firms Have Gotten Creative in COVID-19 Response

May 06, 2020

Greg Fliszar and Danielle Sapega were quoted in The Legal Intelligencer about their pro bono work with the Physician Support Line during the COVID-19 pandemic.

County officials say they must know more about patients to help first responders

April 10, 2020

Greg Fliszar was quoted in The Citizens' Voice discussing what hospitals and health systems can release publicly regarding coronavirus due to HIPAA.

Hospitals Tackling Virus May Need More Than Brief Privacy Waiver

March 19, 2020

Chris Raphaely discussed with Bloomberg Law about HHS using a relax enforcement of the privacy requirements during the public health emergency.

Greg Fliszar Named Co-Chair to ABA Joint Opioid Task Force

September 30, 2019

Greg Fliszar has been named a co-chair of the American Bar Association’s Joint Opioid Task Force (Opioid Task Force).

How In-House Lawyers Can Help Health Care Institutions Fight Costly Data Breaches

September 04, 2019

Greg Fliszar discussed with Law.com how health care providers are handling the rising number of serious data breaches that affect patients.

Trump Administration Expands Pre-Tax Accounts for Health Insurance

June 13, 2019

Alex Campau discussed with The Wall Street Journal about how employees will now be able to use HRAs to buy individual coverage, with certain restrictions, starting January 2020.

57 Cozen O’Connor Lawyers, 16 Practices Earn Top Recognition in Chambers USA 2019 Guide

April 25, 2019

Chambers USA, the leading annual guide to the top lawyers and law firms in the USA, has ranked 57 Cozen O’Connor lawyers as leaders in their respective fields in the Guide’s 2019 edition.

Top 5 Health Policy Predictions for 2019

December 20, 2018

Alex Campau, Principal & Director of Health Policy, shares her predictions about the key health policy trends she anticipates taking center stage in 2019 with Morning Consult.

The ACA's Been Ruled Invalid. What's Next?

December 17, 2018

Christopher Raphaely, co-chair of Cozen O'Connor's Health Care practice group, spoke with Law360 about a Texas federal judge’s declaration that the entire Affordable Care Act is invalid.

Trump Admin. Urges Broad Easing of Health Laws

December 03, 2018

In a recent article published in Law 360, Alexandra Campau, Principal & Director of Health Policy, discusses the recent White House health report, telling Law 360 the report is “more than an academic exercise.”

Updates to the provider reimbursement review board rules [Podcast]

November 28, 2018

Greg Fliszar, a member of Cozen O'Connor's Health Law practice group, was a guest on the Hospital Finance podcast by Besler.

Xcaliber International Receives 15 Additional Orders from the FDA with Cozen O'Connor’s Guidance

September 11, 2018

Cozen O'Connor guided Xcaliber International, Ltd., L.L.C. (Xcaliber) as the organization received 15 additional orders from the U.S. Food and Drug Administration.

Seven Cozen O’Connor Lawyers Named 2019 “Lawyers of the Year” by Best Lawyers in America

August 31, 2018

Cozen O’Connor is proud to announce that seven of the firm’s lawyers have been recognized as “Lawyers of the Year” in their respective practices by Best Lawyers in America, one of the oldest and most highly regarded peer review publications in the legal profession.

126 Cozen O’Connor Attorneys Named to the Best Lawyers in America

August 22, 2018

One hundred twenty-six Cozen O’Connor lawyers from 20 of the firm’s national offices have been selected for inclusion in the 2018 edition of The Best Lawyers in America.

Christopher Raphaely on The Business of Health Care

June 21, 2018

Chris Raphaely, co-chair of Cozen O'Connor's Health Care practice group, was a guest on SiriusXM's Wharton Business Radio.

Medicaid Work Rules Lawsuit Could Have Far-Reaching Impact

June 13, 2018

Mark Gallant, co-chair of Cozen O'Connor's Health Care practice group, spoke with CQ Roll Call about a recent Medicaid lawsuit in Kentucky.

Fifty-four Cozen O’Connor Attorneys Named 2018 Pennsylvania Super Lawyers and Rising Stars

June 12, 2018

Super Lawyers has named 54 Cozen O'Connor attorneys to its 2018 Pennsylvania Super Lawyers and Rising Stars lists.

Fifty Cozen O’Connor Attorneys Ranked by Chambers USA 2018

May 21, 2018

Cozen O’Connor is pleased to announce that Chambers USA has recognized 50 Cozen O’Connor attorneys for 2018 as leaders in their respective fields; 12 attorneys were recognized nationally and 14 were ranked in the top band either nationally or at the state level.

Cozen O’Connor Elects 19 Associates to Membership

April 09, 2018

Cozen O’Connor has elected 19 associates to membership in the firm. The management committee appointed this qualified group of attorneys to membership based on demonstrated professionalism, leadership, dedication, and loyalty to Cozen O’Connor.

Contacts

R. Christopher Raphaely

Co-Chair, Health Care

craphaely@cozen.com

(215) 665-2099

John D. Shire

Co-Chair, Health Care
Co-Chair, ESG

jshire@cozen.com

(202) 747-0775

People

Awards

Cozen O’Connor Recognized as a “Best Law Firm” in 30 Practice Areas Nationwide, 115 Practice Areas Regionally

November 30, 2022

U.S. News & World Report and Best Lawyers recognized Cozen O’Connor as a “Best Law Firm” in 30 practice areas nationwide and 115 practice areas regionally.

13 Cozen O'Connor Attorneys Named 2022 D.C. Super Lawyers and Rising Stars

July 12, 2022

Super Lawyers has named 13 Cozen O’Connor attorneys to its 2022 Washington D.C. Super Lawyers and Rising Stars lists.

Chambers Ranks 86 Cozen O’Connor Lawyers, 22 Practice Areas in Chambers USA 2022 Guide

June 02, 2022

Chambers USA, the leading annual guide to the top lawyers and law firms in the United States, has ranked 86 Cozen O’Connor lawyers as leaders in their respective fields in the guide’s 2022 edition.

49 Cozen O'Connor Attorneys Named Pennsylvania Super Lawyers and Rising Stars

June 01, 2022

Super Lawyers has selected 49 Cozen O'Connor attorneys to the 2022 Pennsylvania Super Lawyers and Rising Stars lists.

Cozen O’Connor Recognized as a “Best Law Firm” in 29 Practice Areas Nationwide, 121 Practice Areas Regionally

November 04, 2021

U.S. News & World Report and Best Lawyers recognized Cozen O’Connor as a “Best Law Firm” in 29 practice areas nationwide and 121 practice areas regionally.

More Than 205 Cozen O’Connor Attorneys Named Best Lawyers and Ones to Watch By The Best Lawyers In America

August 19, 2021

Best Lawyers selected 210 Cozen O’Connor lawyers from 23 of the firm’s nationwide offices for inclusion in the 2022 edition of The Best Lawyers in America.

47 Cozen O'Connor Attorneys Named Pennsylvania Super Lawyers and Rising Stars

May 28, 2021

Super Lawyers has selected 47 Cozen O'Connor attorneys to the 2021 Pennsylvania Super Lawyers and Rising Stars lists.

82 Cozen O’Connor Lawyers, 19 Practices Earn Top Recognition in Chambers USA 2021 Guide

May 26, 2021

Chambers USA, the leading annual guide to the top lawyers and law firms in the United States, has ranked 82 Cozen O’Connor lawyers as leaders in their respective fields in the guide’s 2021 edition; of those, 15 lawyers have been recognized nationally.

Cozen O’Connor Recognized as a “Best Law Firm” in 25 Practice Areas Nationwide, 115 Practice Areas Regionally

November 05, 2020

U.S. News & World Report and Best Lawyers recognized Cozen O’Connor as a “Best Law Firm” in 25 practice areas nationwide and 115 practice areas regionally.

More Than 200 Cozen O’Connor Attorneys Named Best Lawyers and Ones to Watch By The Best Lawyers In America

August 20, 2020

Best Lawyers selected 201 Cozen O’Connor lawyers from 23 of the firm’s nationwide offices for inclusion in the 2021 edition of The Best Lawyers in America© (Copyright 2020 by Woodward/White, Inc., of Aiken, SC).

63 Cozen O’Connor Lawyers, 16 Practices Earn Top Recognition in Chambers USA 2020 Guide

May 14, 2020

Chambers USA, the leading annual guide to the top lawyers and law firms in the United States, has ranked 63 Cozen O’Connor lawyers as leaders in their respective fields in the guide’s 2020 edition.

57 Cozen O’Connor Lawyers, 16 Practices Earn Top Recognition in Chambers USA 2019 Guide

April 25, 2019

Chambers USA, the leading annual guide to the top lawyers and law firms in the USA, has ranked 57 Cozen O’Connor lawyers as leaders in their respective fields in the Guide’s 2019 edition.

126 Cozen O’Connor Attorneys Named to the Best Lawyers in America

August 22, 2018

One hundred twenty-six Cozen O’Connor lawyers from 20 of the firm’s national offices have been selected for inclusion in the 2018 edition of The Best Lawyers in America.

Related Practice Areas

Related Blogs

Health Law Informer

Providing updated news and analysis concerning the world of health law.

Keep up-to-date with the latest news from Cozen O'Connor

Enter your City or Zip.

Probably shouldn't change this:
Sign up to receive alerts, publications, and event / webinar invites.

By submitting your contact information, you are giving Cozen O'Connor consent to contact you via email.